Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate

Clinical Pharmacokinetics · Published 2026-07-30 · DOI 10.1007/s40262-026-01671-z

Free full text

Authors (12)

Hylke Waalewijn, Lisanne A. H. Bevers, Linda L. Lewis, Margaret D. Louey, Sonoko Kawakatsu, Yanan Zheng, Carlo Giaquinto, Alessandra Nardone, David M. Burger, Rob ter Heine, Angela Colbers, Elin M. Svensson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Waalewijn, H., Bevers, L., Lewis, L., et al. (2026). Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-026-01671-z

Related articles